Novavax Inc. logo

Novavax Inc. (NVAX)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
11. 26
-1.56
-12.1685%
$
2.11B Market Cap
- P/E Ratio
- Div Yield
9.87M Volume
-4.28 Eps
$ 12.82
Previous Close
Add Transaction
Day Range
11.11 12.84
Year Range
6.2 13.39
Want to track NVAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Seekingalpha | 4 months ago
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 4 months ago
Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Seekingalpha | 5 months ago
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 5 months ago
NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum

NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum

Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.

Zacks | 5 months ago
Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago.

Zacks | 5 months ago
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.

Zacks | 5 months ago
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 5 months ago
Novavax (NVAX) Outperforms Broader Market: What You Need to Know

Novavax (NVAX) Outperforms Broader Market: What You Need to Know

Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.

Zacks | 6 months ago
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

Zacks | 6 months ago
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Novavax (NVAX) closed at $8.53, marking a +1.31% move from the previous day.

Zacks | 6 months ago
Loading...
Load More